BullFrog AI Holdings (BFRG) Total Current Liabilities (2021 - 2026)
BullFrog AI Holdings' (BFRG) quarterly Total Current Liabilities came in at $706590.0 in Q2 2026, up 3.74% on a YoY basis from $681084.0 in Q2 2025, and up 5.14% quarter-over-quarter from $672022.0 in Q4 2025.
Analysis
BullFrog AI Holdings (BFRG) Total Current Liabilities (2021 - 2026) Analysis & Trends
BullFrog AI Holdings (BFRG) has reported Total Current Liabilities for 6 consecutive years, with $706590.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Current Liabilities rose 3.74% year-over-year to $706590.0; the trailing twelve-month figure through Jun 2026 stood at $706590.0 (up 3.74% YoY), and the FY2025 full-year result was $672022.0, up 14.27% from the prior year.
- Total Current Liabilities rose to $706590.0 in Q2 2026 per BFRG's latest filing, from $672022.0 in the prior quarter.
- Across five years, Total Current Liabilities topped out at $3.1 million in Q4 2022 and bottomed at $184350.0 in Q4 2023.
- Historically, Total Current Liabilities has averaged $934285.9 across 5 years, with a median of $732645.5 in 2025.
- The sharpest annual moves came in 2023 and 2024: Total Current Liabilities sank 94.12% in 2023, then surged 219.01% in 2024.
- Over 5 years, Total Current Liabilities stood at $3.1 million in 2022, then tumbled by 94.12% to $184350.0 in 2023, then soared by 219.01% to $588090.0 in 2024, then climbed by 14.27% to $672022.0 in 2025, then rose by 5.14% to $706590.0 in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $706590.0, $672022.0, and $758701.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 25.50 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 11.02 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 3.94 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 5.53 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 1.58 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 2.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 1.51 Bn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 3.92 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 438.74 Mn |
| 10 | BullFrog AI Holdings | 9.27 Mn | 2.35 Mn | 106,899.00 | 706,590.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 706,590.00 |
| Dec 31, 2025 | 672,022.00 |
| Sep 30, 2025 | 758,701.00 |
| Jun 30, 2025 | 681,084.00 |
| Mar 31, 2025 | 839,397.00 |
| Dec 31, 2024 | 588,090.00 |
| Sep 30, 2024 | 779,037.00 |
| Jun 30, 2024 | 691,493.00 |
| Mar 31, 2024 | 844,530.00 |
| Dec 31, 2023 | 184,350.00 |
| Sep 30, 2023 | 446,050.00 |
| Jun 30, 2023 | 1.14 Mn |
| Mar 31, 2023 | 1.61 Mn |
| Dec 31, 2022 | 3.14 Mn |
| Dec 31, 2021 | 1.02 Mn |